Product Recalls in Mississippi

Product recalls affecting Mississippi — including food, drugs, consumer products, medical devices, and vehicles distributed to Mississippi. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,619 recalls have been distributed to Mississippi in the last 12 months.

49,744 total recalls
2,619 in last 12 months

Showing 95819600 of 49,744 recalls

DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Simvastatin 10 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Ropinirole 2mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Simvastatin 40 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Atorvastatin 10 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Glimepiride 2 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Tadalafil 5 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Atorvastatin 20 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 40mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Doxazosin 2 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Aripiprazole 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 10mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Ropinirole 0.5 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceMarch 20, 2023· Philips North America

Recalled Item: Philips Incisive CT -Computed Tomography X-Ray System Model Number: 72813...

The Issue: Multi-Function Foot Switch Unload Pedal Foot Entrapment-Pressing the Unload...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceMarch 20, 2023· Philips North America

Recalled Item: Philips Incisive CT -Computed Tomography X-Ray System Model Number: 72814...

The Issue: Multi-Function Foot Switch Unload Pedal Foot Entrapment-Pressing the Unload...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceMarch 20, 2023· DermLite LLC

Recalled Item: DERMLITE DL4W Recalled by DermLite LLC Due to Incorrect labeling; Package...

The Issue: Incorrect labeling; Package labeling contains a different serial number then...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund